Novel bis-benzimidazole-triazole hybrids: anticancer study, in silico approaches, and mechanistic investigation
- 13 December 2024
- journal article
- research article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 17 (1) , 93-107
Abstract
Benzimidazole-triazole conjugates are very active hotspot for design and synthesis of promising anticancer agents. The target analogs showed potent and selective cytotoxicity over different cancer cell lines for breast and lung ones. A new series of bis-1,4-disubstituted-1,2,3-triazoles moieties conjugated with a 2-mercapto-benzimidazole 4a-h and 7a-g was synthesized via the click cycloaddition (CuAAC) reaction. The synthesized triazoles were characterized using several spectroscopic tools. In addition, they were tested against variable cell lines representing different cancer types; HepG-2, MCF-7, HCT-116, and A-549. Computational experiments were introduced for understanding their structure-activity relationships. The data revealed the outperformance of 7a-g analogs over 4a-h one with very effective IC50 values; 4-13 µg/mL compared to the reference drugs. Moreover, detailed mechanistic analyses showed potent Aurora-A Kinase expression for the most active analogs 7a and 7d exhibiting IC50; 3.5 and 5.3 over the control cells 8 ng/mL respectively. Additionally, based on their Aurora-A Kinase inhibitory activity, compound 7a was promising in apoptosis induction and cell cycle arrest. Molecular docking studies with Aurora-A Kinase revealed binding behaviors similar to the co-crystallized ligand sunitinib. Finally, this scaffold exhibits cytotoxic activity via apoptosis, enzyme downregulation, and suppression of cell division.Keywords
Funding Information
- Taif University, Saudi Arabia (TU-DSPP-2024-142)
This publication has 83 references indexed in Scilit:
- Facile Synthesis of Benzimidazoles via Oxidative Cyclization of Acyclic Monoterpene Aldehyde with Diamines: Studies on Antimicrobial and in Vivo Evaluation of ZebrafishChemistry & Biodiversity, 2023
- Understanding and targeting resistance mechanisms in cancerMedcomm, 2023
- 1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activitiesArchiv der Pharmazie, 2022
- Synthesis of 1,2,3‐Triazole Tethered Indole Derivatives: Evaluation of Anticancer Activity and Molecular Docking StudiesChemistrySelect, 2022
- Synthesis, Characterization, DNA Binding, Docking, and Anticancer Studies of Novel Bis‐1,2,3‐triazoles PhthalonitrileChemistrySelect, 2020
- 1,2,3‐Triazole hybrids with anti‐HIV‐1 activityArchiv der Pharmazie, 2020
- Synthesis, characterization, molecular docking, and biological activities of coumarin–1,2,3‐triazole‐acetamide hybrid derivativesArchiv der Pharmazie, 2020
- Synthesis, characterization, and antiplasmodial efficacy of sulfonamide‐appended [1,2,3]‐triazolesJournal of Heterocyclic Chemistry, 2020
- New Benzimidazoles and Their Antitumor Effects with Aurora A Kinase and KSP Inhibitory ActivitiesArchiv der Pharmazie, 2015
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009